Annual Securities Report — FY2025
What AuBEX CORPORATION reported for the period from 2025-04-01 to 2026-03-31.
Filed 2026-06-25View the original on EDINET
How much it says
61Detailed
What moved here
25named for the first time
Its own wording
57terms
Which filing this is
35/ 35newest
No officer data yetThis company's filings have not been read for officers yet. Nothing is missing from the filings — the roster simply has not been extracted.
The gist
For the fiscal year ending March 2026, consolidated sales were ¥6,015.307 million and operating income was ¥615.435 million, representing a decline in profit from the previous fiscal year. The Medical Products Business also invested in a factory site in Aira, Kagoshima Prefecture.
Komori's summary of this document, not the document's own words.61Detailed
How much this filing saysA weighted roll-up of 12 rubric dimensions, each scored from a fixed set of questions asked against this filing — built only from the 39 this document could answer. It measures how specific the disclosure is, not whether the company is doing well. Derived from the data, not editorial.
76
Very detailed
68
Detailed
52
Typical
62
Detailed
17
Almost nothing
100
Very detailed
41
Thin
50
Typical
100
Very detailed
53
Typical
55
Typical
50
Typical
R&D spend1億円Money spent making new things.
Cash left over-1億円Cash from the business, less what went into equipment.
Spent on equipment5億円Plants, machines — things meant to last.
Employees124Headcount at the end of this period.
How to read this page
This is not the documentIt is Komori's reading of the filing submitted to EDINET. The original is linked above.
The score is not a verdictIt measures how specific the disclosure is. It says nothing about results or where the share price goes.
When it updatesContent lands once the filing has been read through. Right after submission, the summary can still be empty.